Possibly due to difference in cancer entity, proportion of positive Ki-67 expression was as high as 95% when we followed the recommendations by the International Ki-67 in Breast Cancer working group [42], which we considered not suitable for classifying Ki-67 expression in GaC. This evidence concerns the gene MKI67 and breast carcinoma.